Replies to post #508520 on Anavex Life Sciences Corp (AVXL)

[rx7171]

Can we get the final peer reviewed publication of this article in time for it to be part of the argument for approval?
Or is the raw data acceptable since it is derived from the 48 week 2b/3 trial data submitted in the MAA?